Actualités Merck - MRK

Les meilleurs offres pour accéder les cours en temps réel en illimité
Real-time Level 1 for Canada + USA
Abonnement Mensuel
Seulement
32,99 €
Pro
Abonnement Mensuel
Seulement
52,79 €
Trade Alert US
Abonnement Mensuel
Seulement
52,79 €
Prix hors taxes
Nom Action Symbole Action Marché Type
Merck and Co Inc MRK NYSE Action ordinaire
  Variation Action Variation Action% Cours Dernier Plus Haut Plus Bas Ouverture Clôture Veille Dernier échange
  -0,16 -0,19% 84,52 85,06 84,08 84,97 84,68 00:31:14
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
21/10/201922:30GLOBENewLink Genetics Announces EU Regulatory Committee (CHMP)..
18/10/201914:53DJFRMerck obtient l'avis favorable du CHMP pour deux nouveaux..
18/10/201913:50DJNMerck Gets Positive EU CHMP Opinion for Two New Regimens of..
18/10/201913:37DJNMerck Gets CHMP Positive Opinion for V920 Ebola Zaire Virus..
18/10/201913:00BWMerck Receives Positive EU CHMP Opinion for Two New Regimens..
18/10/201912:45BWMerck Receives EU CHMP Positive Opinion for Investigational..
15/10/201923:33GLOBEBriaCell Announces Closing of Non-Brokered Private Placement..
09/10/201901:00GLOBEBriaCell Therapeutics Corp. to File Amendment to Management..
08/10/201915:55DJNMerck Cuts Emissions by 7%
08/10/201914:00BWMerck Issues 2018/2019 Corporate Responsibility Report
08/10/201910:55DJN4D Pharma Enters Vaccine Collaboration With Merck & Co.
07/10/201912:30GLOBEBriaCell Doses First Patient in Phase I/IIa Study Evaluating..
04/10/201918:43DJFRLe Keytruda de Merck pourrait devenir le médicament le plus..
03/10/201916:39DJNPDS Biotechnology Shares Up 38% on Merck Collaboration
03/10/201915:28DJNNetScientific Shares Jump as Portfolio Company PDS..
02/10/201923:24EDGARStatement of Changes in Beneficial Ownership (4)
02/10/201923:21EDGARStatement of Changes in Beneficial Ownership (4)
02/10/201923:19EDGARStatement of Changes in Beneficial Ownership (4)
02/10/201923:13EDGARStatement of Changes in Beneficial Ownership (4)
02/10/201923:10EDGARStatement of Changes in Beneficial Ownership (4)
02/10/201914:39DJNMerck Gets China OK for Keytruda as Monotherapy for..
02/10/201913:32DJNMerck Gets FDA Priority Review of Dificid in Children
02/10/201912:45BWMerck’s KEYTRUDA® (pembrolizumab) Now Approved as..
02/10/201912:30BWFDA Accepts Two Applications for Merck’s DIFICID®..
01/10/201912:55BWMerck to Hold Third-Quarter 2019 Sales and Earnings..
01/10/201912:30GLOBENote from Chairman of BriaCell Therapeutics – October is..
30/9/201918:19DJNAstraZeneca, Merck Say Lynparza Trial Achieves Primary,..
30/9/201916:30BWLYNPARZA® (olaparib) More Than Doubled Median Radiographic..
30/9/201913:39DJNMerck: Phase 3 Study of Antibacterial Recarbrio Meets Key..
30/9/201913:06DJNWebMD Health to Buy Aptus Health From Merck
30/9/201912:55BWMerck to Present at the 2019 Cantor Fitzgerald Global..
30/9/201912:45BWPivotal RESTORE-IMI 2 Phase 3 Study of Merck’s RECARBRIO™..
29/9/201916:30BWMerck’s KEYTRUDA® (pembrolizumab) Plus Chemotherapy Showed..
29/9/201908:30BWFinal Study Results Evaluating KEYTRUDA® (pembrolizumab)..
28/9/201916:30BWLYNPARZA® (olaparib) Phase 3 PAOLA-1 Trial Significantly..
25/9/201912:30GLOBEBriaCell Appoints Immunology Expert, Dr. Cara L. Haymaker,..
20/9/201917:03GLOBEBriaCell Announces Private Placement of up to $600,000
20/9/201913:52DJNMerck Gets FDA OK For Expanded Pifeltro, Delstrigo..
20/9/201912:45BWMerck’s PIFELTRO™ (doravirine) & DELSTRIGO™..
19/9/201916:00GLOBEBriaCell Announces Public Disclosure: Remarkable Responder..
19/9/201914:52DJNPDS Biotechnology Reviews Data from PDS0101 Study
17/9/201923:56BWFDA Approves KEYTRUDA® (pembrolizumab) plus LENVIMA®..
17/9/201913:59DJFRMerck: la FDA accorde un examen prioritaire à la demande..
17/9/201913:29DJNMerck Gets FDA Priority Review for Investigational Ebola..
17/9/201912:45BWFDA Accepts Merck’s Biologics License Application (BLA) &..
16/9/201912:30GLOBEBriaCell to Present September 19th at 2nd Annual Next Gen..
10/9/201916:46DJNMerck Down Nearly 5%, on Pace for Largest Percent Decrease..
10/9/201914:00BWMerck Announces First Nine “Safer Childbirth Cities”..
10/9/201912:45BWPooled Analysis Continues to Show Merck’s KEYTRUDA®..
09/9/201923:33GLOBEBriaCell Announces Closing of Upsized Non-Brokered Private..
Voir d'autres actualités liées à cette action »
Dernières Valeurs Consultées
NYSE
MRK
Merck
Inscrivez-vous aujourd'hui pour consulter ce titre en streaming sur le Moniteur ADVFN. Vous pourrez ajouter et visualiser jusqu'à 110 des vos actions préférée et c'est complètement gratuit..

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

P: V: D:20191021 22:47:10